Prospective assessment of inter-rater reliability of a neonatal adverse event severity scale

To ensure reproducibility, adverse event tools in clinical trials need validation. Done in a prospective randomized study for the neonatal adverse event scale (NAESS, Inernational Neonatal Consortium effort, C-Path): interrater variability improved ! https

New Research: Prospective assessment of inter-rater reliability of a neonatal adverse event severity scale #pharmacology https://t.co/BuTzqCv6bS